Stamford, Connecticut – December 27, 2021 – A.D.A.M., an innovative 3D implant manufacturing biotech company that was recently named as one of the “emerging technologies to watch in 2022” by The Economist, has announced the launch of its crowdfunding efforts on StartEngine.
A.D.A.M. was founded in 2018 as a mergence of 3D printing and innovation development teams with roots in Ukrainian aerospace and biotech engineering. Today, A.D.A.M. is a US based company with subsidiaries in both Ukraine and Australia. The Ukrainian subsidiary has the main focus on research and development, while the US based company still holds intellectual property and performs business development and marketing functions; and the Australian subsidiary is pivoting the entrance to the Asia – Pacific market.
The initial vision was to create a company with a car-shop-like infrastructure where any human body part can be treated like a replaceable car part. The team then decided to start the development of the project with a focus on bone implants, and followed it up with the creation of proprietary 3D printing technology and material composites for the implants. A.D.A.M.’s exclusive approach to implant manufacturing – using 3D printing – facilitates enhanced production of personalized implants that are cost-effective, and quickly delivered without compromising on the quality.
“Our aim is to greatly improve the manufacturing process in regenerative medicine on a global scale by overcoming the barriers of tissue transplantation and organs’ 3D printing prevailing presently,” said A.D.A.M. CEO, Denys Gurak. “We use biodegradable and bioresorbable materials for improved surgical results within reduced surgical time, and at reduced patient suffering and cost.”
As global healthcare models face scrutiny and the need to restructure processes due to the COVID-19 pandemic, the basic demand for materials (such as human tissue,organs, and titanium implants that currently dominate the market) remains largely unmet due to supply chain vulnerabilities. As an alternative, A.D.A.M.’s 3D-printed implants are not only easier to produce locally, they also support the progressive development of tissue engineering so multiple implant replacements and surgeries are not necessary. “
Bone implants are just the beginning,” said Gurak. “In the years to come, A.D.A.M. aims to revolutionize the medical industry with an end-to-end ecosystem of 3D printed orthopaedic implants and TaaS [technology as a service].”
A.D.A.M. (Advanced Development of Additive Manufacturing) is a futuristic biotech venture that provides 3D-bioprinting services on demand with a primary focus on bone implants. It presents a full scope of related services, provided remotely or on-site. Currently, in the Research and Development stage, A.D.A.M. is designing for medical professionals to complete all steps of the implant printing process from 3D-modeling to receiving a sterilized personalized device, ready for implantation. As a pre-revenue company, A.D.A.M. has identified potential growth opportunities in the orthopaedic surgery, oncology, and CMF, neuro- and plastic surgery markets.
Company Name: A.D.A.M. (Advanced Development of Additive Manufacturing)
Contact Person: Denys Gurak
Email: Send Email
Address:9W Broad St, Office 320
State: CT 06092
Country: United States